<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/10327" />
  <subtitle />
  <id>http://localhost:8080/xmlui/handle/123456789/10327</id>
  <updated>2026-04-09T05:33:34Z</updated>
  <dc:date>2026-04-09T05:33:34Z</dc:date>
  <entry>
    <title>Anti-Ulcer and Antioxidant Activities of Chrysophyllum albidum G. Don. Seeds Cotyledons</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/10351" />
    <author>
      <name>Ayobami Owolabi, Tunde</name>
    </author>
    <author>
      <name>Chigozie Okubor, Philippine</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/10351</id>
    <updated>2025-06-04T03:45:12Z</updated>
    <published>2024-01-01T00:00:00Z</published>
    <summary type="text">Title: Anti-Ulcer and Antioxidant Activities of Chrysophyllum albidum G. Don. Seeds Cotyledons
Authors: Ayobami Owolabi, Tunde; Chigozie Okubor, Philippine
Abstract: Background: Gastric ulcers are prevalent gastrointestinal disorders with significant global implications owing to&#xD;
their prevalence and potential complications. Side effects associated with synthetic drugs have led to the search&#xD;
for alternative treatments. Chrysophyllum albidum, a plant traditionally used to manage various diseases, has&#xD;
been investigated for its potential to alleviate ulcerative conditions. Methods: This study assessed the efficacy of&#xD;
extracts from C. albidum seed cotyledons in mitigating ethanol- and diclofenac-induced ulcers in rats.&#xD;
Phytochemical screening was performed using standard methods and antioxidant activities were evaluated using&#xD;
DPPH scavenging and ABTS+-reducing assays. Results: For ethanol-induced gastric ulcers, extracts at doses of&#xD;
100, 200, and 400 mg/kg produced lesion indices of 7.04 ± 0.44, 5.18 ± 0.38, and 2.53 ± 0.46 mm, respectively,&#xD;
compared to omeprazole's 0.9 ± 1.09 mm. The highest dose showed 87.93% inhibition, which was comparable to&#xD;
that of omeprazole (93.63% inhibition). A similar trend was observed for diclofenac-induced ulcers.&#xD;
Phytochemical analysis revealed the presence of active compounds, such as steroids, flavonoids, polysaccharides,&#xD;
alkaloids, and cardiac glycosides. Antioxidant activity results indicated significant free radical scavenging&#xD;
properties, with an IC50 value of 49.24 μg/mL for DPPH and 15.1 μg/mL for ABTS+ at a dose of 400 mg/kg. These&#xD;
findings demonstrate the notable dose-dependent anti-gastritis and anti-ulcer effects of the extract. Conclusion:&#xD;
This study highlights the potential of C. albidum seed cotyledons as a valuable candidate for gastroprotective drug&#xD;
development and supports their traditional use in treating and preventing gastritis and gastric ulcers.&#xD;
Keywords: antioxidant, alternative treatment, DPPH, phytochemicals, ulcer</summary>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Evaluation of Adverse Drug Reactions (ADRs) in Breast Cancer Patients Who Received Doxorubicin, Cyclophosphamide (AC) and Doxorubicin, Cyclophosphamide, Paclitaxel (AC-T) Chemotherapy at West Nusa Tenggara Provincial Hospital</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/10350" />
    <author>
      <name>Lenysia Puspita Anjani, Baiq</name>
    </author>
    <author>
      <name>Nanda Muriani, Rahma</name>
    </author>
    <author>
      <name>Nurbaety, Baiq</name>
    </author>
    <author>
      <name>Leny Nopitasari, Baiq</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/10350</id>
    <updated>2025-06-04T03:42:43Z</updated>
    <published>2024-01-01T00:00:00Z</published>
    <summary type="text">Title: Evaluation of Adverse Drug Reactions (ADRs) in Breast Cancer Patients Who Received Doxorubicin, Cyclophosphamide (AC) and Doxorubicin, Cyclophosphamide, Paclitaxel (AC-T) Chemotherapy at West Nusa Tenggara Provincial Hospital
Authors: Lenysia Puspita Anjani, Baiq; Nanda Muriani, Rahma; Nurbaety, Baiq; Leny Nopitasari, Baiq
Abstract: Chemotherapy is commonly used to treat breast cancer (BC). Chemotherapy may cause ADRs in&#xD;
patients, affecting their physical and psychological wellbeing. Objective: To understand the adverse drug reaction&#xD;
(ADR) profile in patients with breast cancer who received AC-T and AC chemotherapy at the West Nusa Tenggara&#xD;
Provincial Hospital. Methods: This observational study used cross-sectional data collected from medical records&#xD;
and direct interviews with the patients between May and June. Probability categories were measured using the&#xD;
Naranjo algorithm questionnaire, causality categories were measured using a causality flowchart, and the severity&#xD;
level of ADRs was determined using the Common Terminology Criteria for Adverse Events (CTCAE) 5.0. Results:&#xD;
The probability results for the AC-T regimen were as follows: possible (10 %), probable (54.44 %), and definite&#xD;
(35.56 %). whereas The AC regimen showed categories of possible (6.67%), probable (63.33%), and definite&#xD;
(30%). The causality results for the AC-T regimen were categorized as unlikely (1.11%), possible (12.22%),&#xD;
probable (25.56%), or certain (61.11%), whereas those for the AC regimen were categorized as possible (6.67%),&#xD;
probable (43.33%), or certain (50%). The most common ADRs were alopecia and nausea, with the highest&#xD;
probability in the probable category for AC-T (54.44%) and AC (63.33%), respectively. Conclusion: Respondents&#xD;
who received the AC-T regimen experienced more severe ADRs in terms of hematologic disorders (anemia,&#xD;
leukopenia, and thrombocytopenia) and symptoms of nausea, pain, and fever than those who received the AC&#xD;
regimen.&#xD;
Keywords: chemotherapy, breast cancer, adverse drug reactions (ADRs), probability, common terminology&#xD;
criteria for adverse events (CTCAE)</summary>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Review: Indole Alkaloids and Antimalarial Activity in the Tabernaemontana Species</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/10349" />
    <author>
      <name>Tri Hutami, Anisa</name>
    </author>
    <author>
      <name>Rudyanto, Marcellino</name>
    </author>
    <author>
      <name>Ekasari, Wiwied</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/10349</id>
    <updated>2025-06-04T03:40:39Z</updated>
    <published>2024-01-01T00:00:00Z</published>
    <summary type="text">Title: Review: Indole Alkaloids and Antimalarial Activity in the Tabernaemontana Species
Authors: Tri Hutami, Anisa; Rudyanto, Marcellino; Ekasari, Wiwied
Abstract: Malaria, caused by Plasmodium parasites, is a highly prevalent and lethal illness that shows&#xD;
persistent ability to develop resistance. Antiplasmodial compounds that are indole-based prevent hemozoin&#xD;
formation, exhibiting efficacy against chloroquine-resistant Plasmodium strains. Tabernaemontana is a member&#xD;
of the genus comprised to the Apocynaceae family and has long been known for its efficacy in traditional and&#xD;
herbal tribal medicine. Apocynaceae can be recognized by the existence of indole alkaloids, and Tabernaemontana&#xD;
spp. is widely identifiable for its ability to synthetize a wide variety of indole alkaloids. Objective: This literature&#xD;
review seeks to provide a comprehensive summary of indole alkaloid compounds from Tabernaemontana spp. and&#xD;
the effectiveness of Tabernaemontana spp. as antimalarials. Methods: Preferred Reporting Items for Systematic&#xD;
Reviews and Meta-Analyses (PRISMA) protocols were followed to explore the PubMed, Sage Journal,&#xD;
ScienceDirect, and Wiley Library databases. Results: 23 publications on the antimalarial activity and indole&#xD;
alkaloids of several species of the genus Tabernaemontana were discovered. Conclusion: Various species of&#xD;
Tabernaemontana contain indole alkaloids, and extracts of the plant or parts of the plant and isolates have weak&#xD;
to strong antimalarial activity.&#xD;
Keywords: antimalarial, indole alkaloid, Tabernaemontana spp., Plasmodium spp.</summary>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Analysis of Cayenne Pepper Fruit (Capsicum frutescens) in Inhibiting HMGCoA Reductase Activity as a Treatment for Hypercholesterolemia</title>
    <link rel="alternate" href="http://localhost:8080/xmlui/handle/123456789/10348" />
    <author>
      <name>Ode Muh. Albar, La</name>
    </author>
    <author>
      <name>Tien, Tien</name>
    </author>
    <author>
      <name>Eso, Amiruddin</name>
    </author>
    <id>http://localhost:8080/xmlui/handle/123456789/10348</id>
    <updated>2025-06-04T03:38:37Z</updated>
    <published>2024-01-01T00:00:00Z</published>
    <summary type="text">Title: Analysis of Cayenne Pepper Fruit (Capsicum frutescens) in Inhibiting HMGCoA Reductase Activity as a Treatment for Hypercholesterolemia
Authors: Ode Muh. Albar, La; Tien, Tien; Eso, Amiruddin
Abstract: Hypercholesterolemia is a major cause of cardiovascular disease and its incidence continues to&#xD;
increase. Statins are a group of hypercholesterolemic therapies known to trigger various side effects; therefore,&#xD;
statin alternatives need to be investigated. The cayenne pepper (Capsicum frutescens) contains secondary&#xD;
metabolites that inhibit the activity of cholesterol-forming enzymes (HMG-CoA reductase). Objective: The aim of&#xD;
this study was to identify the ability of C. frutescens fruit to inhibit HMG-CoA reductase activity to prevent&#xD;
hypercholesterolemia. Methods: This was a true experimental study using a posttest-only control group design.&#xD;
The independent variables were n-hexane, methanol, and ethanol extracts of C. frutescens fruit, each with a&#xD;
concentration of 0.01%, with HMG-CoA reductase activity as the dependent variable. Enzymatic activity was&#xD;
measured enzymatically using spectrometry. Results: The mean values of % inhibition from n-hexane, methanol,&#xD;
and ethanol extracts of C. frutescens and pravastatin were 95.74%, 104.70%, 100.11%, and 99.27%, respectively.&#xD;
The average specific activities of n-hexane, methanol, and ethanol extracts of C. frutescens and pravastatin were&#xD;
0.5765, 0.6029, 0.5513, and 0.5716 units/mgP, respectively. There was a significant difference between the sample&#xD;
groups in the inhibition of HMG-CoA reductase activity. HMG-CoA reductase inhibitory activity was highest in&#xD;
the methanol extract, followed by the n-hexane extracts. The activity of these extracts was higher than that of&#xD;
pravastatin alone. Conclusion: The methanol extract showed the best inhibitory activity. C. frutescens has been&#xD;
shown to have great potential in inhibiting the activity of the enzyme HMG-CoA reductase and preventing&#xD;
hypercholesterolemia.&#xD;
Keywords: Capsicum frutescens, HMG-CoA reductase, hypercholesterolemia</summary>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

